Nicoletta Lanese

The treatment Rebyota contains gut bacteria and is approved to prevent a dangerous bacterial infection.

Doctors reported a case of a man who developed a cough due to a large mass in his chest.

Doctors reported an unusual case in which a man's bladder ruptured due to a shingles infection.

A woman was poisoned when she drank bitter gourd juice.

Our anatomy and the nature of paper make paper cuts super painful.

Newborn twins grew from embryos that had been frozen for 30 years.

The World Health Organization will adopt a new name for monkeypox, as the original name is inaccurate and stigmatizing.

Here's the science behind why stubbing your toe is oddly excruciating.

A study hints that soil-borne fungi that can cause disease may be widespread in the U.S.

An experimental gene therapy restored the night vision of two people with leber congenital amaurosis.

A highly pathogenic strain of bird flu has limited the nation's supply of large turkeys ahead of Thanksgiving.

Teplizumab-mzwv is the first drug ever approved to prevent type 1 diabetes in those who are destined to develop the disease.

U.S. poison control centers have received more reports about pediatric benzonatate ingestion in recent years.

A tiny device replicates the interface between uterine tissue and the cells of the placenta in early pregnancy.

Cows fed hemp, which is not yet an approved animal feed, behaved strangely and produced milk with THC.

Scientists identified specific spinal nerve cells that people likely need to regain the ability to walk after paralyzing injuries.

A child with Pompe disease was the first to start treatments before birth.

A surge of viral infections in the U.S. might be contributing to an ongoing amoxicillin shortage, even though antibiotics don't kill viruses.

Contaminated meat and cheese from deli counters have sickened 16 people in six states.

An implanted device allows a man to translate his brain signals into written words.

"Maximus," an exceptionally preserved T. rex skull, will hit the auction block in December.

A clinical trial will test the viability of lab-grown blood cells for transfusions.

A woman who's incredibly prone to tumors carries an unusual genetic mutation.